The Presence of Hurthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates

Ren, Yin; Kyriazidis, Natalia; Faquin, William; Soylu, SELEN; Kamani, Dipti; Saade, Rayan; Torchia, Nicole; Lubitz, Carrie; Davies, Louise; Stathatos, Nikolaos; Stephen, Antonia; Randolph, Gregory

doi:10.1089/thy.2019.0190

The Presence of Hurthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates

Ren Y., Kyriazidis N., Faquin W. C., Soylu S., Kamani D., Saade R., ...Daha Fazla

THYROID, cilt.30, sa.3, ss.425-431, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 30 Sayı: 3
Basım Tarihi: 2020
Doi Numarası: 10.1089/thy.2019.0190
Dergi Adı: THYROID
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
Sayfa Sayıları: ss.425-431
Anahtar Kelimeler: Hurthle cell, fine-needle aspiration, thyroid malignancy, Bethesda System for Reporting Thyroid Cytopathology, rate of malignancy, oncocytes, PREDICT MALIGNANCY, CARCINOMA, NODULES, SYSTEM, MANAGEMENT, BIOPSY
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Background: Hurthle cell/oncocytic change is commonly reported on thyroid fine-needle aspiration (FNA) and may be considered an "atypical cell" by clinicians. This study aims to delineate the association between Hurthle cells in preoperative cytology and subsequent pathology of the indexed thyroid nodule and to report rates of malignancy.